Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of November 5, 2026, HCAT trades at $1.49 with a market cap of $119.66M and a P/E ratio of -0.47. HCAT moved -6.60% today. Year to date, HCAT is -30.35%; over the trailing twelve months it is -47.36%. Its 52-week range spans $0.96 to $5.06. Analyst consensus is neutral with an average price target of $1.83. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HCAT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HCAT recently traded at $1.49. Market cap is $119.66M. P/E ratio is -0.47. Revenue is $292.25M.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $119.66M |
| P/E Ratio |
| -0.47 |
| EPS | $-3.69 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $5.06 |
|---|
| 52-Week Low | $0.96 |
|---|
| Volume | 272.12K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $292.25M |
|---|
| Net Income | $-264.82M |
|---|
| Gross Margin | 0.00% |
|---|
6 analysts cover HCAT: 0 strong buy, 1 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.83.